Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
- Status
- UNKNOWN
- Phase
- N/A
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
- Status
- COMPLETED
- Phase
- NA
Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
- Status
- TERMINATED
- Phase
- PHASE1
Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
- Status
- COMPLETED
- Phase
- PHASE1
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- N/A
Personalized Radiation Therapy for GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
- Status
- UNKNOWN
- Phase
- PHASE1
An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Easing Psychosocial Burden for Informal Caregivers
- Status
- COMPLETED
- Phase
- EARLY_PHASE1